Citadel Advisors’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Citadel Advisors’s Portfolio RNA Stock Details RNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,000	Closed	-$75K	–	9254
2014 Q4	$75K	Sell	4,000 -17,300	-81%	-$246K	﹤0.01%	6909
2014 Q3	$180K	Sell	21,300 -38,200	-64%	-$362K	﹤0.01%	5834
2014 Q2	$751K	Buy	59,500 +48,400	+436%	+$393K	﹤0.01%	3864
2014 Q1	$62K	Buy	11,100 +300	+3%	+$1.86K	﹤0.01%	6602
2013 Q4	$50K	Buy	10,800 +3,300	+44%	+$15K	﹤0.01%	6043
2013 Q3	$50K	Buy	+7,500	New	+$176K	﹤0.01%	5795

Citadel Advisors's RNA Position: Q4 2014 in Review

Citadel Advisors sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2014, closing a stake of 2,148 shares — an estimated $30.5K sold.

Citadel Advisors first reported a position in RNA in Q3 2013 and held it in 5 quarters. The position peaked at $88K in Q4 2013. 47 funds tracked by Wall St. Rank hold RNA as of Q4 2014.

Citadel Advisors reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2014 after selling out during the quarter.
Citadel Advisors sold 2,148 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2014, an estimated $30.5K.
Citadel Advisors first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and held it in 5 quarters.
Citadel Advisors's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $88K in Q4 2013.
47 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.